Veterinary Medicine Information website

NEUMOSUIN

Authorised
  • Actinobacillus pleuropneumoniae, serovar 5, Inactivated
  • Actinobacillus pleuropneumoniae, serovar 4, Inactivated
  • Actinobacillus pleuropneumoniae, serovar 2, Inactivated

Product identification

Medicine name:
NEUMOSUIN
Active substance:
  • Actinobacillus pleuropneumoniae, serovar 5, Inactivated
  • Actinobacillus pleuropneumoniae, serovar 4, Inactivated
  • Actinobacillus pleuropneumoniae, serovar 2, Inactivated
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Actinobacillus pleuropneumoniae, serovar 5, Inactivated
    4.00
    billion organisms
    /
    2.00
    millilitre(s)
  • Actinobacillus pleuropneumoniae, serovar 4, Inactivated
    4.00
    billion organisms
    /
    2.00
    millilitre(s)
  • Actinobacillus pleuropneumoniae, serovar 2, Inactivated
    4.00
    billion organisms
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AB07
Authorisation status:
  • Valid
Authorised in:
  • Bulgaria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Hipra, S.A.
Responsible authority:
  • Bulgarian Food Safety Authority
Authorisation number:
  • 0022-1574-07.06.2011
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 17/05/2022

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 17/05/2022